Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus dexmedetomidine for postoperative sleep quality in elderly ERCP patients
ChiCTR2100052435Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (3 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: Pittsburgh Sleep Quality Index (PSQI), Sleep quality and 1 more. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100052435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052435.